Bilbo-Basurtuko Erakunde Sanitario Integratua
Osakidetzako erakundea
Centro Nacional de Biotecnología
Madrid, EspañaCentro Nacional de Biotecnología -ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2017
-
Corrigendum: Identification of rare PB2-D701N mutation from a patient with severe influenza: Contribution of the PB2-D701N mutation to the pathogenicity of human influenza [Front. Microbiol. 8, 575 (2017)] doi: 10.3389/fmicb.2017.00575
Frontiers in Microbiology
-
Identification of rare PB2-D701N mutation from a patient with severe influenza: Contribution of the PB2-D701N mutation to the pathogenicity of human influenza
Frontiers in Microbiology, Vol. 8, Núm. APR